stockrow
Friday 6 November 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- +55.6%
- Free cash flow
- −3.19%
- Total debt
- +662.8%
Quarter to September 2026, against a year earlier
36.82
3.18
−7.95%
Follow PNTG
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 8 | 6 | 6 | 3 | 6 | — | — | — | — |
P/E ratio |
32.36 | 36.83 | 31.56 | 46.87 | 288.50 | 101.86 | 312.57 | 37.31 | 37.31 | 37.31 |
Altman Z-Score |
2.29 | 2.71 | 1.91 | 1.57 | 1.85 | 3.26 | 2.22 | — | — | — |
P/S ratio |
1.03 | 1.19 | 0.78 | 0.66 | 1.49 | 4.16 | 2.72 | 1.30 | 1.30 | 1.30 |
P/FCF ratio |
26.84 | 27.29 | 16.97 | 0.00 | 0.00 | 37.89 | 324.16 | 29.92 | 29.92 | 29.92 |
Altman Z″-Score (non-manufacturers) |
1.45 | 1.75 | 1.01 | 0.69 | 0.49 | 0.21 | 0.07 | — | — | — |
Beneish M-Score |
(2.52) | (2.23) | (2.49) | (2.54) | (2.13) | (2.50) | (1.96) | — | — | — |
P/Operating CF |
46.42 | 40.22 | 81.86 | (79.72) | (127.11) | (564.47) | (348.45) | 51.27 | 51.27 | 51.27 |
P/B ratio |
2.60 | 2.65 | 2.91 | 2.49 | 5.74 | 16.09 | 12.95 | 4.98 | 4.98 | 4.98 |
Price to Tangible BV |
0.00 | 9.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 43.72 | 43.72 | 43.72 |
EV/Sales |
1.19 | 1.54 | 0.91 | 0.83 | 1.63 | 4.22 | 2.81 | 2.05 | 2.05 | 2.05 |
EV/EBITDA |
18.43 | 23.66 | 16.17 | 21.52 | 72.03 | 68.96 | 99.50 | 42.07 | 42.07 | 42.07 |
EV/Operating CF |
23.39 | 27.30 | 15.06 | 43.21 | (39.40) | 32.86 | 99.54 | 34.30 | 34.30 | 34.30 |
EV/FCF |
31.16 | 35.40 | 19.94 | (76.23) | (29.27) | 38.41 | 334.86 | 47.09 | 47.09 | 47.09 |
Quick Ratio |
0.95 | 1.04 | 0.94 | 0.79 | 0.83 | 0.53 | 0.64 | 0.83 | 0.85 | — |
Current Ratio |
1.14 | 1.21 | 1.12 | 1.05 | 1.06 | 0.67 | 0.76 | 0.99 | 1.02 | — |
Net Debt/EBITDA |
2.56 | (0.53) | 1.88 | 4.26 | 6.25 | 0.93 | 3.18 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
17.96% | 0.00% | 11.84% | 15.53% | 12.73% | 4.42% | 6.88% | 0.00% | 0.00% | — |
Debt/Equity |
0.46 | 0.00 | 0.44 | 0.63 | 0.59 | 0.22 | 0.43 | 0.00 | 0.00 | — |
Asset Turnover |
1.15 | 1.14 | 1.04 | 0.91 | 0.85 | 0.82 | 1.24 | 5.83 | 2.69 | 0.00 |
Operating CF/Net income |
1.63 | 1.74 | 2.47 | 1.36 | (6.76) | 3.19 | 3.75 | 1.48 | 1.75 | 2.08 |
Capex/Depreciation |
(1.28) | (1.25) | (1.43) | (2.61) | (1.20) | (1.45) | (1.73) | (1.22) | (0.99) | 0.00 |
Interest Coverage |
7.77 | 5.48 | 4.25 | 3.34 | 2.42 | 15.27 | 13.83 | — | — | — |
| 8.62% | 9.86% | 9.87% | 5.54% | 2.50% | 18.28% | 3.73% | 26.08% | 17.80% | 0.00% | |
| 3.59% | 3.70% | 2.54% | 1.27% | 0.52% | 3.30% | 0.93% | 31.96% | 10.58% | 0.00% | |
ROIC |
6.11% | 8.28% | 7.73% | 3.92% | 1.66% | 9.57% | 3.49% | 19.76% | 0.00% | — |
Return on Tangible Assets |
36.46% | 35.00% | 36.04% | 22.00% | 12.84% | (136.52%) | 119.25% | 156.31% | 106.82% | 0.00% |
Average Days of Receivables |
47.41 | 42.68 | 40.94 | 41.20 | 44.78 | 44.09 | 34.70 | 31.22 | 32.35 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
7.50% | 7.22% | 6.73% | 7.18% | 8.25% | 8.01% | 10.38% | 6.59% | 5.76% | 5.73% |
Intangible Assets out of Total Assets |
0.45 | 0.33 | 0.29 | 0.27 | 0.24 | 0.22 | 0.17 | 0.57 | 0.00 | — |
Share Based Compensation of Revenue |
0.94% | 1.12% | 0.99% | 0.65% | 2.28% | 2.13% | 1.00% | 0.83% | 0.92% | 0.00% |
Graham Net Nets |
(0.44) | (0.30) | (0.74) | (1.00) | (0.52) | (0.21) | (0.37) | (0.58) | (0.58) | (0.58) |
Graham Number |
14.56 | 12.73 | 7.02 | 4.73 | 2.69 | 6.80 | 2.47 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.09% | 2.71% | 3.17% | 2.13% | 0.35% | 0.98% | 0.32% | 2.68% | 2.68% | 2.68% |
Free Cash Flow Yield |
3.73% | 3.66% | 5.89% | (1.64%) | (3.74%) | 2.64% | 0.31% | 3.34% | 3.34% | 3.34% |
Revenue per Share |
27.42 | 22.29 | 18.25 | 16.28 | 15.48 | 13.95 | 12.16 | 10.28 | 9.02 | 7.76 |
Operating CF per Share |
1.40 | 1.26 | 1.11 | 0.31 | (0.64) | 1.79 | 0.34 | 0.84 | 0.62 | 0.59 |
Capex per Share |
(0.35) | (0.29) | (0.27) | (0.49) | (0.22) | (0.26) | (0.24) | (0.13) | (0.09) | 0.00 |
Free Cash Flow per Share |
1.05 | 0.97 | 0.84 | (0.18) | (0.86) | 1.53 | 0.10 | 0.71 | 0.53 | 0.59 |
Cash per Share |
0.49 | 0.78 | 0.20 | 0.07 | 0.18 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
10.83 | 10.00 | 4.87 | 4.32 | 4.02 | 3.61 | 2.55 | 2.35 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.83 | 10.00 | 4.87 | 4.32 | 4.02 | 3.61 | 2.55 | 2.35 | 0.00 | 0.00 |
Free Cash Flow |
36.26 | 30.31 | 24.99 | (5.13) | (24.53) | 42.95 | 2.84 | 19.67 | 14.74 | 16.41 |
Working Capital |
20.14 | 21.16 | 8.53 | 3.58 | 4.21 | (29.42) | (12.51) | (0.42) | 0.44 | — |
Capital Expenditures |
(12.04) | (8.99) | (8.10) | (14.17) | (6.30) | (7.25) | (6.71) | (3.60) | (2.51) | (3.47) |
Net Current Asset Value |
(426.52) | (244.70) | (314.10) | (312.64) | (340.21) | (346.20) | (337.96) | (3.74) | 26.70 | — |
EV/EBIT |
21.77 | 28.14 | 19.80 | 30.67 | 152.91 | 87.21 | 167.73 | 51.37 | 51.37 | 51.37 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
Price to Operating Income |
18.75 | 21.70 | 16.85 | 24.59 | 139.64 | 86.03 | 162.36 | 32.64 | 32.64 | 32.64 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.17 | 0.20 | 0.20 | 0.31 | 0.28 | 0.27 | 0.28 | 0.29 | 0.00 |
Cash ROIC |
6.42% | 9.01% | 11.59% | (2.47%) | (13.12%) | 34.75% | 2.78% | 30.11% | 40,938.89% | 0.00% |
Accounts Receivable Turnover |
9.27 | 9.76 | 9.51 | 8.82 | 8.69 | 9.85 | 11.95 | 12.25 | 10.75 | 0.00 |
Accounts Payable Turnover |
37.22 | 40.67 | 39.03 | 34.27 | 38.51 | 36.50 | 45.07 | 65.25 | 165.22 | 144.97 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
11.24 | 11.37 | 8.28 | 12.01 | 9.85 | 10.60 | 10.75 | 6.58 | 5.14 | (0.82) |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
102.21 | 71.21 | 57.27 | 53.68 | 50.58 | 39.70 | 28.33 | 23.36 | 23.36 | — |
Average Payables |
21.95 | 14.79 | 12.24 | 12.10 | 10.16 | 9.21 | 6.52 | 3.73 | 1.32 | 1.32 |
Average Assets |
823.85 | 609.61 | 525.91 | 521.21 | 518.64 | 477.36 | 272.95 | 49.08 | 93.22 | — |
Average Common Equity |
343.11 | 228.74 | 135.59 | 119.95 | 107.71 | 86.14 | 68.20 | 60.14 | 55.43 | — |
Columns are period end dates · fundamentals updated 4 Nov 2026